# US 2022/0031789 A1 · Method of chinese herbal medicine extract used for treating multiple diseases caused by drug resistant bacteria infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031789 A1
- Document ID: US20220031789A1
- Status: Published application
- Kind: A1
- Application number: 17/494,858
- Filed: 2021-10-06
- Published: 2022-02-03
- Earliest claimed: 2016-05-10
- Assignees: Sun Yat-Sen University
- Applicants: Sun Yat-Sen University
- Inventors: Weiwei Su; Chong Liu; Qian Zhou; Peibo Li; Wei Peng; Yonggang Wang
- Web page: https://patentgrep.com/patent/US20220031789A1

## CPC

- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61P 31/04: Antibacterial agents
- A61K 2236/331: using water, e.g. cold water, infusion, tea, steam distillation or decoction
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Disclosed is a new drug application of a Pithecellobium Clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter Baumannii (MDRAB), an MDR Pseudomonas Aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia Coli (ECO) and an ESBL-producing Klebsiella Pneumonia (KPN).

## Claims

### Claim 1

A method of treating a disease caused by an Extended-Spectrum Beta-Lactamase producing Klebsiella Pneumonia infection, comprising administering a Pithecellobium Clypearia Benth Extract (EA), wherein the EA is a water extract or ethanol extract.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Pithecellobium clypearia Benth water extract or the Pithecellobium clypearia Benth ethanol extract is prepared with a following method: extracting Pithecellobium clypearia Benth coarse powder with water or an ethanol aqueous solution having a concentration of 10%-95% by a volume ratio, and then extracting an obtained extracting solution with ethyl acetate, in which the obtained extract is a final product.

### Claim 3 (depends on 2)

The method of claim 2, wherein the ethanol aqueous solution is an ethanol aqueous solution having the concentration of 60% by the volume ratio.
